Therefore, the increased expression of S100A11 in GBM cells could promote GBM cell proliferation, EMT, migration, invasion and neurosphere formation by activating the ANXA2‐mediated NF‐κB signalling pathway. Here, S100A11 is linked to glioblastoma.